Clinical Trial Update: Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing adherence in patients receiving once-daily versus twice-daily fixed-dose glimepiride/metformin therapy for Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• glimepiride/metformin fixed-dose combination (glimepiride/metformin)

Snippet

Sponsor: Handok Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED